MedTrace Logo

Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients

NCT04356404 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2022-01-28

No results posted yet for this study

Summary

The purpose of this study is to study the risk of hepatitis flare in patients with previous hepatitis B virus exposure amongst patients on immunosuppressive and biological modifier therapies

Conditions

  • Occult Hepatitis B
  • Biological Substance; Adverse Effect
  • Immunosuppression

Sponsors & Collaborators

  • University of Malaya

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • WingYan Mak, MRCP · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2022-01-12
Completion
2022-01-12

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04356404 on ClinicalTrials.gov